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Abstract 
Platyhelminth parasites are a major health problem in 
developing countries. In contrast to their mammalian hosts, 
platyhelminth thiol-disulfide redox homeostasis relies on 
linked thioredoxin-glutathione systems, which are fully 
dependent on thioredoxin-glutathione reductase (TGR), 
a promising drug target. TGR is a homodimeric enzyme 
comprising a glutaredoxin domain and thioredoxin reductase 
(TR) domains with a C-terminal redox center containing 
selenocysteine (Sec). In this study, we demonstrate the existence 
of functional linked thioredoxin-glutathione systems in the 
cytosolic and mitochondrial compartments of Echinococcus 
granulosus, the platyhelminth responsible for hydatid disease. 
The glutathione reductase (GR) activity of TGR exhibited 
hysteretic behavior regulated by the [GSSG]/[GSH] ratio. 
This behavior was associated with glutathionylation by 
GSSG and abolished by deglutathionylation. The Km and kcat 
values for mitochondrial and cytosolic thioredoxins (9.5 µM 
and 131 s–1, 34 µM and 197 s–1, respectively) were higher than 
those reported for mammalian TRs. Analysis of TGR mutants 
revealed that the glutaredoxin domain is required for the GR 
activity but did not affect the TR activity. In contrast, both 
GR and TR activities were dependent on the Sec-containing 
redox center. The activity loss caused by the Sec-to-Cys 
mutation could be partially compensated by a Cys-to-Sec 
mutation of the neighboring residue, indicating that Sec can 
support catalysis at this alternative position. Consistent with 
the essential role of TGR in redox control, 2.5 µM auranofin, 
a known TGR inhibitor, killed larval worms in vitro. These 
studies establish the selenium- and glutathione-dependent 
regulation of cytosolic and mitochondrial redox homeostasis 
through a single TGR enzyme in platyhelminths. 
Abbreviations: Sec, selenocysteine; DMEM, Dulbecco’s modified 
Eagle’s medium; DTNB, 5,5’-dithiobis(2-dinitrobenzoic acid); DTT, 
dithiothreitol; EGFP, enhanced green fluorescent protein; GR, 
glutathione reductase; Grx, glutaredoxin; GSSG, glutathione(oxidi
zedform); TGR, thioredoxinglutathione reductase; TR, thioredoxin 
reductase; Trx, thioredoxin; SECIS, selenocysteine insertion sequence; 
mtTrx, mitochondrial Trx; cTrx, cytosolic Trx. 
The control of parasitic infections, which are a major cause of disability, mortality, and economic losses in many 
developing countries, remains as one of the most important 
challenges for medicine in the 21st century (1). In the case of 
the phylum platyhelminthes (flatworms), which include the 
causative agents of schistosomiasis (bilharzia) and hydatid 
disease, pharmacotherapy with praziquantel has met 
great success in the treatment of infection. However, drug 
resistance is a serious issue as it has been the case for other 
antiparasitic drugs (2). In the case of platyhelminths, this 
may have severe consequences, because praziquantel is the 
only drug that is readily available for large scale treatment 
of these infections (3). Thus, the need for new drugs and/or 
vaccines is of great importance. In recent years, evidence has 
accrued that the selenocysteine (Sec)2-containing enzyme 
thioredoxin glutathione reductase (TGR) is essential for 
platyhelminth parasites and has emerged as a rational target 
for chemotherapy and/or immunotherapy (4–8). In most 
organisms, including the mammalian hosts of platyhelminths, 
cellular redox homeostasis, antioxidant defenses, and supply 
of reducing equivalents to several targets and essential 
enzymes rely on two major pathways: the glutathione (GSH) 
and the thioredoxin (Trx) systems, which have overlapping 
and differential targets and functions (9, 10). In contrast, 
platyhelminth parasites lack conventional thioredoxin 
reductase (TR) and glutathione reductase (GR), and hence 
conventional Trx and GSH systems (4, 6, 7). Instead, they 
rely exclusively on linked thioredoxin-glutathione systems, 
with TGR being the key enzyme that provides reducing 
equivalents to both pathways. Another feature of the linked 
systems in platyhelminths is that cytosolic and mitochondrial 
TGR derive from a single gene and have identical sequence, 
once the leader peptide of the mitochondrial variant is 
removed (5). In the mammalian hosts, different thioredoxin 
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reductase isozymes function in the cytosol and the 
mitochondria (11, 12), TGR expression is largely restricted 
to testis (13), and GR exists as a distinct gene (14). In sum, 
the dissimilar arrangements of redox pathways as compared 
with their hosts, the lack of back-up systems, and the fact that 
parasitic organisms are subjected not only to the endogenous 
oxidative stress, but also to the oxidative challenge imposed 
by the host’s immune system, provide a strong rationale to 
target platyhelminth TGRs. Recent studies support this idea: 
inhibition of TGR expression by RNA interference caused 
death of the platyhelminth parasite Schistosoma mansoni, 
and auranofin, a potent inhibitor of TGR and Sec-containing 
TRs (15), caused a partial cure in experimental Schistosoma 
infection (8). 
TGR possesses a fusion of conventional TR domains with 
a glutaredoxin (Grx) domain (13, 16). TGR, like GR and TR, 
is a homodimer, with monomers oriented in a head-to-tail 
manner. Based on biochemical data, the current model of 
the mechanism of reaction for TGR proposes that electrons 
flow from NADPH to FAD, to the C156XXXXC redox center 
(numeration according to Echinococcus granulosus TGR), to 
the C-terminal GC595UG (U is Sec) redox center of the second 
subunit, and finally to the C31XXC redox center of the Grx 
domain of the first subunit. The fully reduced enzyme can 
reduce either oxidized Trx using the C-terminal active site 
GCUG, or GSSG through the CXXC redox center of the Grx 
domain (13, 17). Recently, a crystallographic structure of an S. 
mansoni C-terminally truncated TGR (GCstop) has been solved. 
Based on the residual GR activity of the mutant, the authors 
proposed an alternative view in which GSSG could be reduced 
directly by the CXXXXC redox center of TR domains (18). 
In the current study, we have characterized the linked 
thioredoxin-glutathione system of the platyhelminth E. 
granulosus, the causative agent of hydatid disease. We 
demonstrated the occurrence of functional linked systems in 
both cytosol and mitochondria. The analysis of activities of 
TGR mutants revealed that the Grx domain is required for 
the GR activity, but does not affect the TR activity; in contrast, 
both Trx- and glutathione-dependent activities require 
selenocysteine (Sec) residue. Our results also indicate that 
[GSSG]/[GSH] ratio regulates TGR activities and strongly 
suggest that glutathionylation/deglutathionylation is involved 
in this regulation. In addition, we show that larval worms are 
killed by very low concentrations of auranofin, a TGR inhibitor, 
and discuss our results in light of the current models that have 
been put forward to explain the GR activity of TGR. 
Experimental Procedures 
 
Cloning of Mitochondrial Isoforms of Trx and TGR as 
N-terminal Fusions to EGFP
To analyze the subcellular localization of the putative 
mitochondrial variants of Trx and TGR, constructs were 
generated using pEGFP-N2 (Clontech). In the case of Trx, the 
sequence was retrieved from Partigen (cluster EGC03292), 
and the entire coding region, including the leader peptide, 
was cloned as an in-frame fusion to EGFP. In the case 
of TGR the N-terminal fragment of mitochondrial TGR, 
containing the leader peptide followed by the Grx domain of 
TGR, was cloned as an EGFP fusion. In both cases, a Kozak 
consensus sequence was included in the forward primer for 
initiation of translation at the first AUG codon. For transient 
expression, mouse NIH 3T3 cells (ATCC) were cultured in 
DMEM supplemented with 10% fetal bovine serum in the 
presence of 100 units/ml penicillin and 50 units/ml nystatin. 
Transfections were carried out in 35-mm glass bottom culture 
dishes using Lipofectamine 2000 (Invitrogen), according to the 
manufacturer’s instructions. Transfection mix was prepared 
using 3 µg of plasmid DNA (mitochondrial Trx construct, 
mitochondrial TGR construct, or pEGFP-N2, used as a control) 
and 6 µl of Lipofectamine per dish. Transfections were carried 
out in Opti-MEM (Invitrogen) for 8 h. The transfection medium 
was replaced with a DMEM culture medium containing 
MitoTracker Red CM-H2XRos (Molecular Probes),
 a marker 
of the mitochondrial compartment; cells were incubated for 
30 min and then washed twice with DMEM. Transiently 
transfected cells were detected by confocal microscopy (Bio-
Rad, MRC1024ES laser scanning microscope). 
Cloning, Expression, and Purification of Recombinant 
TGR and Its Mutants
Different constructs were made for expression of wild-
type TGR (TGRGCUG) (where U is Sec, and GCUG is the C-
terminal tetrapeptide) and the following mutants: Sec596 to Cys 
(TGRGCCG), Sec596 to stop (TGRGC*), Sec596 to Cys, and Cys595 
to Sec (TGRGUCG), as well as a mutant lacking the entire Grx 
domain of TGR (TRGCUG). In all cases mRNA from trizoled E. 
granulosus protoscoleces (larval worms) was used as a template 
for reverse transcription and PCR, using ThermoScript reverse 
transcriptase (Invitrogen) and Pfu (Fermentas), respectively. 
Forward and reverse gene-specific primers were derived 
from the previously published TGR sequence (5). In the 
case of mutant TGRs, the reverse primers were modified 
appropriately. For Sec-encoding constructs (TGRGCUG, 
TGRGUCG, and TRGCUG), further engineering of the reverse 
primers was needed to specify Sec, because the UGASec codon 
requires recoding by an Sec insertion sequence (SECIS) element 
present in the selenoprotein mRNAs. Thus, for these constructs, 
the reverse gene-specific primer contained, at the 5’-end, the 
SECIS element of Escherichia coli formate dehydrogenase H at 
a 10-nucleotide distance from the UGASec codon (sequences 
of primers for every construct are detailed in supplemental 
Table S1). This strategy with a bacterial-type SECIS has been 
previously used for C-terminal Sec incorporation in E. coli (19). 
The amplified products were first cloned into pGEM-T-easy 
(Promega), and the construct sequences were verified prior 
to subsequent subcloning into pET28a (Novagen). Constructs 
were used to transform E. coli BL21(DE3) cells, or, in the 
case of selenoprotein constructs, BL21(DE3) cells previously 
transformed with pSUABC, a plasmid that supports high 
level expression of genes involved in Sec synthesis and 
decoding (selA, selB, and selC) (19). Expression of recombinant 
proteins was carried out following the protocol described in a 
previous study (20), which has been optimized for expression 
of selenoproteins. Essentially, induction of recombinant 
proteins was carried out with 100 µM isopropyl 1-thio-β-D-
galactopyranoside at late exponential phase (A600 = 2.4), during 
24 h at 24 °C. Recombinant clones were grown in modified LB 
media according to a previous study (21), supplemented with 
0.1 g/liter cysteine and 0.37 g/liter methionine (22), in the 
presence of kanamycin (50 µg/ml), and chloramphenicol (33 
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µg/ml); the latter was used only in the case of bacterial cultures 
harboring the TGRGCUG, TGRGUCG, and TRGCUG constructs. At 
the time of induction the culture was supplemented with 5 µM 
sodium selenite, 20 µg/ml riboflavin, 20 µg/ml pyridoxine, 
and 20 µg/ml niacin according to a previous study (21). For 
recombinant TGRs that did not contain Sec (TGRGCCG and 
TGRGC*) the same protocol was followed, except that the 
plasmid pSUABC was not used. The bacterial cultures were 
centrifuged, and the pellets were resuspended in modified 
nickel-nitrilotriacetic acid lysis buffer (300 mM NaCl, 50 mM 
sodium phosphate, 20 mM imidazole, pH 7.2) containing 1 
mM phenylmethylsulfonyl fluoride and 1 mg/ml lysozyme, 
and sonicated (10 pulses of 1 min with 1-min pauses). The 
lysates were centrifuged for 1 h at 30,000 x g, and supernatants 
were applied to a nickel-nitrilotriacetic acid column (Qiagen), 
washed with 300 mM NaCl, 50 mM sodium phosphate, 30 mM 
imidazole, pH 7.2, and eluted with 250 mM imidazole. The 
protein-containing fractions were applied to PD10 desalting 
columns (GE Healthcare) using phosphate-buffered saline, 150 
mM potassium chloride, 50 mM sodium phosphate, pH 7.2. 
Fractions containing the recombinant proteins were stored at –
70 °C before use. Total protein concentration and FAD content 
were determined spectrophotometrically at 280 (ε = 54.24 
mM–1 cm–1) and 460 nm (ε = 11.3 mM–1 cm–1), respectively. The 
selenium content of selenoproteins was determined by atomic 
absorption using a Plasma Emission Spectrometer (Jarrell-
Ash 965 ICP) in Chemical Analysis Laboratory, University of 
Georgia. The purity of the recombinant proteins was analyzed 
by running 10% SDS-PAGE gels, under reducing conditions, 
and by size-exclusion chromatography on a Superose 12 
column (GE Healthcare). 
Cloning, Expression, and Purification of E. granulosus 
Recombinant Mitochondrial and Cytosolic Trx Forms
mRNAs encoding cytosolic and mitochondrial E. granulosus 
Trxs were amplified by reverse transcription-PCR from total 
larval worm mRNA as described above. Specific forward 
and reverse primers for cytosolic and the predicted mature 
mitochondrial Trx were derived from previously published 
sequences (23) and from Partigene (cluster EGC03292), 
respectively. The amplified products were first cloned into 
pGEM-T-easy (Promega), sequenced and subsequently 
subcloned into pET28a (Novagen) using appropriate 
restriction enzymes. Constructs were used to transform E. coli 
BL21(DE3) host cells. Expression of recombinant proteins was 
carried out following the standard protocol for expression of 
recombinant proteins. Essentially, recombinant clones were 
grown on LB in the presence of kanamycin, and induction of 
recombinant proteins was carried out with 100 µM isopropyl 
1-thio-β-D-galactopyranoside at early exponential phase (A600 
= 0.5), for 3 h at 37 °C. The bacterial cultures were centrifuged, 
and the recombinant proteins were purified and desalted as 
described above for TGR, except that all buffers had pH 7.8. 
Fractions containing the recombinant proteins were stored 
at –70 °C prior to use. Protein concentration was determined 
spectrophotometrically at 280 nm (ε = 7.6 and 6.1 mM–1 
cm–1 for cytosolic and mitochondrial Trx, respectively). The 
purity of the recombinant proteins was analyzed by running 
15% SDS-PAGE gels under reducing conditions, and by size 
exclusion chromatography on a Superdex 75 column (GE 
Healthcare). 
Metabolic Labeling of Selenoproteins
To label cells with 75Se, E. coli cells carrying the different 
constructs were grown at 37 °C until A600 reached 0.4, and 
the culture was supplemented with ~50 µCi 75Se (as freshly 
neutralized sodium selenite, specific activity of 1000 Ci/
mmol, Research Reactor Facility, University of Missouri, 
Columbia, MO). After an additional 30 min, isopropyl 1-thio-
β-D-galactopyranoside was added to each cell culture at a final 
concentration of 100 µM. After 3 h of induction at 37 °C, cells 
were collected, washed, and lysed by boiling in SDS-PAGE 
sample buffer containing 50 mM 1,4-dithiothreitol (DTT). Cell 
lysates were then subjected to SDS-PAGE followed by transfer 
of proteins onto a polyvinylidene difluoride membrane. 75Se 
signal was visualized with a phosphorimaging device (Fuji). 
Enzymatic Assays
Insulin Reduction Assay for Trx Activity—The efficient 
reduction of two interchain disulfides of insulin catalyzed 
by Trx in the presence of DTT was used as a measure of Trx 
activity, according to a previous study (24). The reaction 
was followed by the increase in absorbance at 650 nm due to 
the precipitation of free insulin B-chain. The 0.8-ml reaction 
mixtures contained 0.33 mM DTT, 130 µM insulin, and 2 mM 
EDTA in 100 mM potassium phosphate buffer, pH 7.0. Runs 
with DTT alone were performed as controls. 
DTNB Reduction Assay for TR Activity—The reduction of 5,5’-
dithiobis (2-dinitrobenzoic acid) (DTNB) with concomitant 
NADPH oxidation was determined by the increase in 
absorbance at 412 nm due to formation of 5’-thionitrobenzoic 
acid at 25 °C (25). The 0.8-ml reaction mixtures contained 0.2 
mM NADPH, 5 mM DTNB, and 10 mM EDTA in 100 mM 
potassium phosphate buffer, pH 7.0. 
Insulin Reduction Assay for TR Activity—The Trx-coupled 
assay of TR activity takes advantage of the NADPH-dependent 
reduction of Trx by TR, which is followed by the decrease in 
absorbance at 340 nm; in this assay, excess of insulin is used 
as an electron sink to maintain a constant concentration of 
oxidized Trx (25). The 0.8-ml reaction mixtures contained 
0.2 mM NADPH, 1 mM EDTA, 0.5 mg/ml insulin, and E. 
granulosus cytosolic or mitochondrial Trx (concentrations 
ranged from 0 to 80 µM and from 0 to 140µM, respectively), 
in 50 mM potassium phosphate buffer, pH 7.0. The kinetic 
parameters of TGR with its physiological substrates, cytosolic 
and mitochondrial Trx, were determined from Michaelis-
Menten plots of vo (derived from time-course experiments) 
against substrate concentration. 
GR Assay—The GR activity was assayed as NADPH-
dependent reduction of oxidized glutathione (GSSG), which 
is followed as the decrease in absorbance at 340 nm (26). The 
0.8-ml reaction mixture contained 0.125 mM NADPH, 1 mM 
GSSG, 1 mM EDTA in 100 mM potassium phosphate buffer, 
pH 7.0. 
All enzymatic assays were carried out in a Cary 50 (Varian) 
spectrophotometer at 25 °C. Analyses of the kinetic data were 
performed using ORIGIN software (OriginLab). 
Mass Spectrometry Analysis—Wild-type TGR samples (10 
nM concentration) were incubated with GSSG in the presence 
or absence of 0.125 mM NADPH at molar ratios under which 
hysteresis was or was not observed (1 mM or 30 µM GSSG, 
respectively) in 100 mM potassium phosphate buffer, pH 7.0, 
containing 1 mM EDTA, and immediately passed through a 
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PD10 desalting column (GE Healthcare). Protein-containing 
fractions were digested with trypsin and subjected to analysis 
by matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (4800 Analyzer, Applied Biosystems). The 
mass spectrometry analysis was carried out at the Institut 
Pasteur, Montevideo. 
In Vitro Culture of Larval Worms—50,000 protoscoleces, 
obtained from asceptical punction of a single hydatid cyst 
from bovine lung, were washed several times with phosphate-
buffered saline and then incubated at 37 °C, 5% CO2, in 
DMEM supplemented with antibiotics and 20 mM HEPES, 
pH 7.4. Cultured protoscoleces were treated with 1, 2.5, 5, and 
10 µM auranofin or with the vehicle (DMSO), in the presence 
or absence of 100 µM hydrogen peroxide. Protoscoleces were 
observed under the microscope, and viability was assessed 
by exclusion of the vital dye eosin. 
Results 
 
Mitochondrial Localization of Trx and TGR Forms—Sequence 
analyses suggested the occurrence of both cytosolic and 
mitochondrial forms of TGR and Trx, with TGR forms 
generated from a single gene, and two genes for Trx forms. 
The results of transient expression in mammalian NIH 3T3 
cells of the predicted mitochondrial forms of Trx and TGR 
are shown in Figure 1. Both EGFP fusion proteins co-localized 
with MitoTracker, indicating that the signal peptides of these 
proteins direct the fusions to the mitochondrial compartment. 
No obvious staining of the cytosol or other subcellular 
compartments was observed. TGR has been previously shown 
to be present in the mitochondrial subcellular fraction of a 
larval worm aqueous extract (5); however, the mitochondrial 
location of Trx was previously limited to in silico predictions 
in platyhelminths (7). 
TGR Can Provide Electrons to Both Cytosolic and Mitochondrial 
Trx Forms—Prior to determining the enzymatic parameters 
of TGR with its physiological substrates, the quality of every 
recombinant protein was assessed in several ways. First, 
the purity of TGR and its mutants, and of cytosolic and 
mitochondrial Trx forms, was determined by SDS-PAGE 
under reducing conditions (Figure 2A) and by size exclusion 
chromatography (data not shown). In the case of selenoproteins, 
Sec incorporation was evaluated by metabolic labeling of the 
bacterial cultures with 75Se. The results are shown in Figure 2 
Figure 1. Subcellular localization of GFP-fused mitochondrial 
TGR and mtTrx. NIH3T3 cells were transiently transfected either 
with the non-recombinant pEGFP vector (A) or with the pEGFP-
derived constructs carrying mitochondrial TGR (B) and mtTrx (C) 
N-terminally fused to GFP. Images were obtained at 8 h post-
transfection using an I-confocal microscope. A set of three panels 
is shown for each construct. Left panels show green fluorescence 
corresponding to transiently expressed GFP fusion proteins. 
Center panels show the red fluorescence of the mitochondrial dye 
(MitoTracker). The right panels show merged images from left and 
center panels. 
Figure 2. Analysis of recombinant proteins. A, SDS-PAGE analysis of purified recombinant proteins. After purification on a nickel-
nitrilotriacetic acid column and desalting, recombinant proteins were run on a 12.5% polyacrylamide gel. 1 µg of each recombinant protein 
was loaded on the gel. Lanes 1–5, TGRGCUG, TRGCUG, TGRGUCG, TGRGCCG, TGRGC*, respectively; lane 6, molecular weight markers; lane 7, 
mtTrx; and lane 8, cTrx. The positions of molecular weight marker are indicated on the right. B and C. 75Se incorporation into recombinant 
TGRs. BL21(DE3) cells expressing TGRGCUG, TGRGUCG, TGRGCCG, and TGRGC* were induced with 100 µM isopropyl 1-thio-β-D-galactopyranoside 
for 3 h at 37 °C. 50 µCi of 75Se were added to 10-ml cultures 30 min before induction. Total cell protein samples were resolved by SDS-
PAGE and transferred onto a polyvinylidene difluoride membrane. B, Coomassie Blue staining of the polyvinylidene difluoride membrane. 
C, 75Se detection by phosphorimaging device analysis. Lanes 1–4, 10 µl of total cell protein samples from cells expressing recombinant 
TGRGCUG, TGRGUCG, TGRGCCG, and TGRGC*, respectively; lane 5, molecular weight marker. FDH-O, formate dehydrogenase O (110 kDa), the 
single selenoprotein expressed by E. coli under aerobic conditions. The bands around 66 kDa are indicated by an asterisk on lanes 1 and 2 
on the right panel and correspond to 75Se-labeled Sec-containing recombinant TGRs. Lower molecular mass bands on these lanes probably 
correspond to secondary initiation or degradation products of these Sec-containing recombinants. The absence of bands on lanes 3 and 4 
indicates no unspecific selenium incorporation was detected. The positions of molecular weight markers are indicated on the right. 
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(B and C); specific labeling at the expected molecular weight 
was observed exclusively in the bacterial lysates expressing 
selenoproteins, indicating that full-length selenoproteins were 
synthesized. In addition, the selenium content of recombinant 
selenoproteins was determined. Sec incorporation was close 
to 10% in all recombinant selenoproteins (9.2% for wild-type 
TGRGCUG, 7.4% for inverted TGRGUCG, and 8.7% for TRGCUG). 
Taken together, all these data indicated that the strategy was 
successful to produce full-length TGR in a bacterial host, 
although higher percentages of Sec incorporation (up to 50%) 
have been previously reported using this methodology for 
other selenoproteins (19). Because only a fraction of the TGR 
molecules incorporate Sec (due to prevalent termination of 
translation at Sec UGA codons), active protein concentrations 
of selenoproteins were corrected according to their selenium 
content. 
The activities of recombinant TGR and Trx were initially 
assessed independently of each other, using the DTNB and 
insulin reduction assays (see “Experimental Procedures”), 
respectively. Both recombinant enzymes displayed activity 
in these independent assays (data not shown). Then, using 
the insulin coupled assay, the kinetic parameters of TGR with 
its physiological substrates, cytosolic and mitochondrial Trx, 
were determined from Michaelis-Menten plots of vo against 
substrate concentration (Figure 3). Km and kcat values were of 
the same order for both Trxs (Figure 3, Table 1). The catalytic 
efficiency of TGR was (13.8 ± 0.9) x 106, and (5.8 ± 0.4) x 106 
M–1 s–1 for mitochondrial and cytosolic Trx, respectively. 
Sec but Not the Grx Domain Is Essential for TR Activity—To 
assess the role of the Grx domain and of Sec at the GCUG C-
terminal redox center of TGR in the catalysis, we generated a 
set of TGR forms: wild-type TGR (TGRGCUG), TRGCUG (without 
 
 
 
 
 
 
 
 
 
 
 
 
 
the Grx domain), Sec596 to stop mutant (TGRGC*), Sec596 to 
Cys mutant (TGRGCCG), and Cys595 to Sec and Sec596 to Cys 
double mutant (TGRGUCG). Analysis of TR activity with the 
DTNB assay (shown in Figure 4 and summarized in Table 
1) revealed that TRGCUG and wild-type TGR have similar 
kcat. TGRGC* had negligible activity even at 500 nM enzyme 
concentration (data not shown). TGRGCCG had a kcat more than 
two orders of magnitude lower than that of wild-type TGR. 
The double mutant with Sec and Cys at inverted positions, 
TGRGUCG, had a kcat one order of magnitude higher than that 
of the Sec596 to Cys mutant. We next evaluated the kinetic 
parameters of the mutants with mitochondrial Trx. The results 
are summarized in Table 1. The catalytic efficiency (kcat/Km) 
of the Sec to Cys mutant was 2.5 orders of magnitude lower 
than that of the wild-type TGR, whereas the double mutant 
was approximately one order of magnitude higher than the 
Cys mutant (Table 1). Both TR assays indicated that, although 
the Grx domain did not affect the TR activity, the C-terminal 
Sec residue was essential for this activity. Interestingly, a 
Figure 3. Kinetic parameters of TGRGCUG with mtTrx and 
cTrx. Apparent Km and kcat of TGRGCUG with mtTrx and cTrx 
were obtained using the Trx-coupled assay. The initial reaction 
velocities (v0) at different Trx concentrations were measured at 
a constant and saturating NADPH concentration (200 µM) and 
a constant enzyme concentration (0.5 nM). Plots of v0 versus 
substrate concentration for mtTrx and cTrx are shown. The data 
were fitted to the Michaelis-Menten equation using Origin 7.5 
software. Apparent Km and vmax were obtained from these fittings 
and apparent kcat was calculated from apparent vmax. Apparent 
Km, kcat, and kcat/Km values are indicated. The enzyme (TGRGCUG) 
concentration used for kcat calculation was corrected according to 
its selenium content. 
Figure 4. TR activity of TGR mutants. The TR activities of wild-
type and mutant TGRs were compared using the DTNB assay. The 
assay was carried out at constant and saturating concentrations of 
DTNB and NADPH (5 mM and 200 µM, respectively) and different 
concentrations of each enzyme. The plots of initial velocities (v0) 
versus enzyme concentration are shown. The selenoenzyme 
(TGRGCUG, TRGCUG, and TGRGUCG) concentrations used for kcat 
calculations were corrected according to their selenium contents. 
Table 1. Kinetic parameters of wild-type TGR and its 
mutants. Apparent kinetic parameters for mtTrx and cTrx 
(physiological TGR substrates) were obtained by varying the 
mtTrx and cTrx concentrations at a constant and saturating 
concentration of NADPH and constant enzyme concentrations. 
Apparent kcat values for DTNB were determined from the slope 
of the initial velocities (v0) versus enzyme concentration plots 
(Figure 4). The enzyme concentrations used for kcat calculations 
for selenoproteins (TGRGCUG, TRGCUG, and TGRGUCG) considered the 
actual concentrations of active enzymes (i.e. their values were 
corrected according to their selenium content).
Parameter             Substrate      TGRGCUG     TRGCUG        TGRGUCG       TGRGCCG
Apparent Km  mtTrx  9.5 ± 0.5  13.0 ± 0.6  12.0 ± 0.6  14.3 ± 0.6
   (μm)  cTrx  34 ± 2
Apparent kcat (s–1) mtTrx  131 ± 2  80 ± 2  6.4 ± 0.2  0.530 ± 0.007
 cTrx  197 ± 3
 DTNB  118 ± 3  60 ± 3  6.0 ± 0.5  0.63 ± 0.03
Apparent kcat/Km  mtTrx  13.8 ± 0.9  6.1 ± 0.4  0.27 ± 0.03  0.037 ± 0.002
(μm–1s–1)  cTrx  5.8 ± 0.4
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Sec residue at the resolving position of the C-terminal redox 
center could partially compensate for the loss of activity due 
to Sec to Cys mutation. 
GR Activity Exhibits Hysteretic Behavior That Is Dependent 
on the Ratio of Oxidized and Reduced Glutathione—A hysteretic 
behavior (i.e. the existence of a lag time before catalysis takes 
place) of the GR activity of TGR was previously reported for 
the TGR of Taenia crassiceps (another platyhelminth parasite) 
(6). This behavior has not been reported for E. granulosus, S. 
mansoni, or mammalian TGR (5, 13, 27). We observed that E. 
granulosus TGR exhibited hysteretic behavior for its GR activity, 
which became evident at TGR concentrations below 15 nM 
(Figure 5A) or high GSSG concentrations (Figure 5B). Although 
the results were analogous to those described for T. crassiceps 
TGR, the E. granulosus TGR exhibited less marked hysteresis 
(i.e. lower lag times for similar experimental conditions). 
Rendón et al. (6) described that preincubation of TGR with GSH 
abolishes the hysteretic behavior of the enzyme. We found that 
preincubation was not needed to relieve GR hysteresis of E. 
granulosus TGR (Figure 5C). Although the lag time correlated 
directly with the concentration of GSSG, and inversely with 
the concentration of GSH, the maximal slope of the curves did 
not significantly change once the enzyme was fully active (see 
Figure 5, B and C). We next assayed whether Trx can relieve GR 
hysteresis and found that 20 µM Trx, without preincubation, 
abolished the hysteretic behavior (Figure 5D). 
GR Activity Is Reversibly Regulated by Glutathionylation/
Deglutathionylation—Rendón et al. (6) have postulated that TGR 
must possess two GSH-binding sites, one of them regulatory, 
with high affinity for reduced GSH. We examined binding of E. 
granulosus TGR to a glutathione matrix and found that neither 
oxidized nor NADPH-reduced TGR associated with GSH-
agarose. Because the [GSSG]/[GSH] ratio controls the activity 
of the enzyme, we reasoned that TGR may be glutathionylated 
by GSSG at high concentrations and deglutathionylated by 
GSH. Thus, we incubated 10 nM TGR with NADPH and 1 
mM GSSG for 1 min (conditions at which the enzyme is still 
under hysteresis, see Figure 5B) and for 10 min (the enzyme is 
no longer under hysteresis, see Figure 5B). We then subjected 
the enzymes to tryptic digest and mass spectrometry analysis. 
The results indicated that TGR is glutathionylated at two Cys 
residues: Cys88 and Cys354 after 1-min incubation with 1 mM 
GSSG and NADPH (supplemental Figure S1). Absence of 
NADPH did not prevent glutathionylation. In contrast, after 
10-min incubation with 1 mM GSSG and NADPH, TGR was 
found to be deglutathionylated (supplemental Figure S1). In 
similar experiments, no glutathionylation was found when 
10 nM TGR was incubated for 1 min with 30 µM GSSG (a 
concentration under which there is no hysteresis, see Figure 
5B) with or without NADPH. In all cases, neither the Cys 
residues belonging to the Grx active site nor those of the 
CXXXXC catalytic redox center of TGR were detected as 
glutathionylated peptides; instead, they were detected to be 
forming disulfides. Some Cys-containing peptides, including 
the Sec-containing peptide could not be detected. Altogether 
the results indicated that the enzyme is glutathionylated 
at high GSSG concentrations and suggest that it becomes 
deglutathionylated once the enzyme is active. 
We then tested whether the TR activity was preserved in 
TGR at conditions at which the GR activity was under hysteresis. 
Because it is not possible to measure the TR activity of TGR in 
the presence of GSSG, we incubated 10 nM TGR with 1 mM 
GSSG for 1 min (conditions under which there is GR hysteresis 
and glutathionylation) and applied the glutathionylated TGR 
Figure 5. Hysteretic behavior 
of GR activity of TGR. Full-time 
courses obtained using different 
assay conditions are shown. In all 
cases the reactions were started 
by the addition of TGRGCUG at the 
indicated final concentrations. A, 
effect of enzyme concentration. 
Assays were performed at varying 
TGRGCUG concentrations and constant 
NADPH and GSSG concentrations 
(100 µM and 1 mM, respectively). B, 
effect of GSSG concentration. GSSG 
concentration was varied at constant 
NADPH and enzyme concentrations 
(100 µM and 10 nM, respectively). 
Note that at 31 and 62 µM GSSG 
reactions come to their end at 
higher A340, i.e. before depleting 
NADPH, because GSSG becomes the 
limiting reagent. C, effect of GSH 
concentration. GSH was included 
at various concentrations while 
maintaining constant GSSG, NADPH, 
and enzyme concentrations (1 mM, 
125 µM, and 10 nM, respectively). D, 
effect of Trx concentration. cTrx was 
added at different concentrations to 
reaction mixtures containing 1 mM 
GSSG, 125 µM NADPH, and 10 nM 
TGRGCUG. The TGRGCUG concentration 
considered was corrected according 
to its selenium content. 
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to a PD10 desalting column to remove GSSG. We measured 
the TR activity of this treated TGR by both the insulin-coupled 
(Figure 6A) and DTNB assays (data not shown) finding no 
hysteretic behavior. In contrast, the GR activity of the treated 
TGR was under hysteresis at low GSSG concentrations 
(condition under which there is no hysteresis if the enzyme 
was not pretreated) (Figure 6B). In addition, we examined 
whether Grx domain contributed to glutathionylation. For 
this purpose, we evaluated glutathionylation and TR activity 
of TRGCUG at high [GSSG]. We found that the TR activity was 
unaffected at high [GSSG] using the Trx-coupled assay (Figure 
6C); however, the peptide containing Cys354 was not detected 
in TRGCUG (either native or glutathionylated). 
Both the Grx Domain and the Sec Residue Are Essential for GR 
Activity—We further investigated whether the GR activity 
was affected by the Grx domain and the Sec residue at the C-
terminal redox center. TRGCUG, TGRGCCG, and TGRGC* did not 
display significant activity at the standard conditions of the 
assay (i.e. 1 mM GSSG), even at high concentrations of enzymes 
(200 nM). Because the phenomenon of hysteresis observed 
for the GR activity is dependent not only on the enzyme 
concentration, but also on GSSG and GSH concentrations, 
we evaluated the activity of these mutants at high enzyme 
concentrations (200 nM) and different concentrations of 
GSSG and in the presence of GSH. None of these enzymes 
exhibited significant activity at low GSSG concentrations (30 
µM) (Figure 7A), and addition of 1 mM GSH did not affect 
the enzymatic activity (data not shown). Altogether, these 
results indicated that the C-terminal and Grx redox centers 
are essential for GR activity. Interestingly, and similar to what 
was observed for the TR activity, the double mutant TGRGUCG 
exhibited significant GR activity (Figure 7B). We then studied 
the effect of GSH addition on the GR activity of the double 
mutant. At high concentration of GSSG (1 mM), the addition 
of 1 mM GSH abolished hysteresis (Figure 7C). Finally, we 
examined whether a combination of functional TR domains 
(TRGCUG) with functional Grx domain (TGRGC*) displays GR 
activity. No activity was observed at high concentrations of 
both proteins, indicating that electron transfer between these 
two proteins is not efficient. This also rules out the possibility 
that the ~10-fold Grx excess with respect to functional TR 
domains present in TGRGCUG and TGRGUCG (due to the 
prevalent truncated forms present in these preparations) can 
affect the GR activity of these selenoproteins. 
Figure 6. TR activity of TGRGCUG and TRGCUG analyzed at the hysteresis conditions for GR activity. A, the TR activities of untreated 
and glutathionylated TGRGCUG were compared using the Trx-coupled assay. B, the GR activities of untreated and glutathionylated TGRGCUG 
were compared at 100 µM GSSG. In both A and B the enzyme preparations were assayed at 1 nM TGR concentration and 150 µM NADPH. 
It should be noted that, to calculate the volume of enzyme preparation that ought to be used in the assay, glutathionylated TGR was 
assumed to be 2-fold diluted following desalting. This approximation could explain the slightly smaller slopes observed for this enzyme 
in both assays, as compared with the untreated one. C, the TR activity of TRGCUG was evaluated using the Trx-coupled assay both in the 
absence and presence of high concentration (1 mM) GSSG. The enzyme was assayed at 1 nM final concentration and 150 µM NADPH. The 
selenoenzyme (TGRGCUG and TRGCUG) concentrations considered were corrected according to their selenium contents. 
Figure 7. GR activity of TGR mutants. Time courses obtained for the GR activity of wild-type TGR and its mutants are shown. In all 
cases the reaction was started by the addition of the enzymes at the indicated final concentrations. A, comparison of the GR activity 
of TGRGCUG, TGRGCCG, TGRGC*, and TRGCUG at 31 µM GSSG and 125 µM NADPH. B, the GR activity of TGRGUCG at different enzyme 
concentrations was evaluated at 31 µM GSSG and 125 µM NADPH. C, the effect of GSH addition on the hysteretic behavior of TGRGUCG 
was studied by including GSH at 1 mM in a reaction mixture containing 1 mM GSSG, 125 µM NADPH, and 25 nM TGRGUCG. The enzyme 
concentrations for selenoproteins (TGRGCUG, TRGCUG, and TGRGUCG) were corrected according to their selenium contents. 
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Auranofin, a TGR Inhibitor, Kills Larval Worms at Low 
Concentrations—Because glutathione and thioredoxin 
activities depend on TGR in both compartments, mitochondria 
and cytosol, we evaluated, in animal culture, the effects of 
auranofin on protoscoleces (larval worms). All protoscoleces 
were dead 12 h after addition of 10 µM auranofin. The 
disruption of protoscoleces tegument integrity was the first 
microscopic sign of the drug effect; latter changes included 
disorganization of the protoscolex parenchyma (Figure 8). 
At 5 µM auranofin, 20% of protoscoleces were dead at 12 
h, and 100% at 30 h. At 2.5 µM auranofin, all protoscoleces 
were dead after 48 h, whereas at 1 µM auranofin, 90% of 
protoscoleces survived, but development toward cyst was 
severely compromised. We then evaluated the effect of 
auranofin on protoscoleces subjected to oxidative stress (100 
µM hydrogen peroxide). A lower percentage of protoscoleces, 
only 60%, survived at 1 µM auranofin. 
Discussion 
 
Previous studies have shown that TGR is an essential 
enzyme in platyhelminth parasites and an attractive target 
for drug and/or vaccine development (8). In this study, 
we provide further evidence that validates TGR as a key 
platyhelminth molecule to target. We have previously shown 
that cytosolic and mitochondrial variants of TGR from E. 
granulosus derive from a single gene and have the same amino 
acid sequence, once the leader peptide of the mitochondrial 
isoform is removed. We now show, by transient expression 
in eukaryotic cells that the mitochondrial variant of TGR and 
a putative mitochondrial Trx from E. granulosus localize to 
the mitochondrial compartment when assessed by confocal 
microscopy. No experimental evidence for mitochondrial co-
localization of platyhelminth TGR and Trx had been previously 
reported. We thus also proved that TGR provides electrons to 
E. granulosus cytosolic and mitochondrial Trxs as well as to 
GSSG, indicating the existence of TGR-dependent functional 
thiol systems in cytosol and mitochondria. Furthermore, 
TGR functions equally well with both Trx isozymes, with a 
catalytic efficiency of 107 M–1 s–1, similar to the values reported 
for other TGRs and TRs. The Km and kcat values for Trxs are 
higher than those reported for mammalian TRs (~3 µM and 
40 to 60 s–1, respectively) (15, 28, 29). However, Km values 
of the TGRs of the phylogenetically closest organisms to E. 
granulosus (T. crassiceps and S. mansoni) are also higher than 
those for mammalian TRs. The reported kcat values for these 
TGRs are lower than the reported herein for E. granulosus 
TGR, but it should be noted that no corrections by protein 
selenium content have been done in those cases (6, 8). 
During characterization of the GR activity of E. granulosus 
TGR we observed that at low concentrations the enzyme 
exhibited hysteretic behavior. Furthermore, we showed that 
the [GSSG]/[GSH] ratio controlled the activity of the enzyme: 
the lag time correlated directly with GSSG concentration 
and inversely with GSH concentration. Hysteretic behavior 
has been associated with changes in conformation and/
or oligomerization in response to substrates, products, or 
modifiers (30). We did not detect changes in the oligomerization 
state of TGR upon incubation of the enzyme with high GSSG 
concentrations by size exclusion chromatography (data not 
shown). Our results strongly indicated that the observed 
hysteretic phenomenon correlated to the glutathionylation 
state of TGR as summarized in Figure 9. Further evidence that 
the hysteretic behavior of TGR was due to glutathionylation 
derived from the fact that, once GSSG was removed using 
a desalting column, the glutathionylated enzyme was 
hysteretic even at low GSSG concentrations. Of the two Cys 
residues found to be glutathionylated, Cys88 is present in 
vertebrate TGRs and in Grx, whereas Cys354 is present only 
in E. granulosus TGR (supplemental Figure S2). Interestingly, 
Cys88 is close to the mobile linker of Grx-TR domains (100–
105), and Cys354 is located close to a solvent accessible mobile 
loop (359–363) (18). Glutaredoxins have been shown to 
Figure 8. Auranofin effect on 
E. granulosus larval worms. 
Protoscoleces were incubated in vitro 
at 37 °C, 5% CO2 in DMEM with 10 
µM auranofin, a TGR inhibitor, or its 
vehicle (DMSO) as a control. A, control 
protoscoleces after 30 h of culture. 
B, treated protoscoleces after 12 h 
of culture (all protoscoleces were 
dead, note the disorganization of the 
parenchyma and the loss of the hooks 
or the entire crown of hooks). C, treated 
protoscoleces after 30 h of culture. The 
scale bar on C corresponds to 100 µm. 
Figure 9. Hysteretic behavior and glutathionylation of TGR. 
At high GSSG concentrations, the GR activity of TGR exhibited 
hysteretic behavior (filled squares); TGR was found to be 
glutathionylated under hysteresis and deglutathionylated once 
hysteresis was abolished. At low GSSG concentrations, the GR 
activity did not exhibit hysteretic behavior (open squares), and 
the enzyme was not glutathionylated. The figure also shows that 
hysteretic behavior is favored by high [GSSG]/[GSH] ratios or low 
enzyme concentrations and is relieved at low [GSSG]/[GSH] ratios 
or high enzyme concentrations. 
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catalyze deglutathionylation of target proteins (31–33). Thus, 
an additional issue relates to whether deglutathionylation is 
autocatalyzed by TGR. We observed deglutathionylation of 
TGR by GSH in the absence of NADPH (data not shown). 
This suggests that deglutathionylation under these conditions 
can occur, but catalysis by the Grx domain cannot be ruled 
out. Because TGR catalyzes numerous thiol-(selenol)-based 
reactions, and at the same time its activity is controlled 
by the [GSSG]/[GSH] ratio, it constitutes an interesting 
model to study enzymatic regulation by glutathionylation/
deglutathionylation, as well as substrate inhibition and 
product activation phenomena. 
The fact that hysteresis is found at high GSSG concentrations 
raises the question of whether this phenomenon takes place in 
vivo. It should be noted that parasites are under oxidative stress 
mainly due to the host’s immune response. This generates 
not only GSSG, but also thiyl radicals, sulfenic acids, and S-
nitrosylated glutathione and protein intermediates, which 
have been proposed as glutathione donors and acceptors for 
protein-SSG formation, respectively (34). Glutathionylation of 
proteins has been proposed to regulate diverse intracellular 
signaling pathways, particularly in mammalian cells under 
oxidative stress (9, 31, 34) and to provide a protective 
mechanism for the damaging effects of oxidative agents 
(34, 35). Our results indicated that TGR activity is preserved 
for reduction of Trx during oxidative stress; under these 
conditions TGR would be inactivated for the GR function, 
whereas the TR function would remain unaffected. 
To gain further insights into the catalytic mechanism of 
TR and GR activities of TGR, we generated a set of constructs 
designed to study the roles of its C-terminal redox center 
and the N-terminal Grx domain. Consistent with the results 
obtained for mammalian TGR (17), we found that the Sec 
residue of TGR is essential for both activities. The Sec to 
stop mutant (a truncated mutant at the penultimate amino 
acid) has negligible GR and TR activities. Furthermore, a 
Sec to Cys mutation also results in a remarkable loss of TR 
activity and almost complete loss of GR activity. These results 
indicated that in E. granulosus the overall redox homeostasis is 
controlled by TGR and is dependent on selenium. A striking 
observation was that the additional mutation at the C-terminal 
redox center (TGRGUCG) partially compensated for the loss of 
activity caused by the single Sec to Cys mutation (TGRGCCG). 
This recovery of activity was observed with all substrates 
studied: DTNB, thioredoxin, and GSSG. Selenoprotein redox 
active sites are characterized by the presence of Sec at the 
nucleophilic (attacking) position, and a Cys residue is usually 
observed at the resolving position of the catalytic mechanism 
(17, 36–38). The higher nucleophilicity and low pKa of the 
selenol group of Sec (39) are thought to confer Sec a catalytic 
advantage over Cys at the attacking position. In addition, 
recent evidence supports the model that Sec is the leaving 
group during reduction of the C terminus during the catalytic 
cycle (38). No natural selenoprotein with Sec at the resolving 
position has been described (40), and it is assumed that Sec 
would not confer a significant advantage to the catalytic 
efficiency when present at this position. Furthermore, a 
semisynthetic mammalian TR with an inverted C-terminal 
active site resulted in 100-fold decrease in catalytic activity 
(comparable to the Sec to Cys mutant) (38). Our results 
suggest that Sec not only provides a catalytic advantage over 
Cys at the nucleophilic position, but a Cys to Sec mutation 
at the resolving position can also enhance enzymatic activity 
compared with the corresponding Cys form. The fact that 
Sec is superior to Cys at the resolving position of the redox 
active center may also apply to other selenoproteins and the 
corresponding thiol oxidoreductases. It would be interesting 
to explore this possibility in the context of engineering Cys-
containing enzymes for enhanced catalysis. 
Regarding the role of the Grx domain in TGR functions, 
the comparison of wild-type TGR and TR revealed that the 
Grx domain does not positively or negatively affect the TR 
activity of the enzyme, indicating that the Grx domain neither 
assists nor hinders the TR activity of TGR. In contrast, the TR 
module of TGR has no GR activity, and thus both the Grx and 
TR domains are needed for this activity. 
Our data clearly indicate that efficient GSSG reduction 
requires both the C-terminal Sec-containing redox center and 
the N-terminal Grx domain, in agreement with the model 
originally proposed for mammalian TGR (13), and later 
supported by characterization of the enzyme (17). This model 
put forward that electrons can flow from the C-terminal 
GCUG redox center directly to Trx, or to the N-terminal 
CXXC redox center of the Grx domain and finally to GSSG. 
This implies that a conformational switch must exist to allow 
either Trx or the “in built” Grx domain to receive electrons 
from the C-terminal redox center. An alternative electron 
pathway for GSSG reduction has recently been suggested 
based on the crystallographic structure of a C-terminally 
truncated S. mansoni TGR. To account for the residual GR 
activity of the truncated enzyme, the authors proposed that 
GSSG could be reduced directly by the CXXXXC redox center 
of TR domains (18). The fact, that auranofin, an inhibitor of 
Sec-containing TRs and TGRs, inhibits not only TR but also 
GR activities of S. mansoni TGR, suggests that the proposed 
alternative electron pathway is marginal and is unlikely to be 
physiologically relevant (8, 27). 
Finally, we performed in vitro studies on E. granulosus larval 
worms to evaluate the effects of auranofin. Concentrations 
as low as 2.5 µM of auranofin kill all larval worms within 
48 h, and lower concentrations severely hampered in vitro 
development of larval worms toward cyst. The effect of the 
drug on larval worms challenged with hydrogen peroxide 
was even more marked. Low concentrations of auranofin 
have also been reported to rapidly kill juvenile and adult S. 
mansoni in culture. Mammalian cells, however, are able to 
survive higher concentrations of auranofin (8). 
Data available indicate that in platyhelminth parasites the 
biochemical scenario of thiol-disulfide redox homeostasis 
differs greatly from that of their mammalian hosts. In 
platyhelminths, the overall redox homeostasis is controlled 
by TGR and is dependent on selenium. The substitution of 
conventional Trx and GSH systems by linked systems makes 
TGR (the molecular link for Trx and glutathione-dependent 
functions) a target molecule for drug or vaccine development. 
In this study, we demonstrated the existence of functional 
linked systems in both mitochondria and the cytosol that 
depends on a single TGR. Thus, targeting this enzyme can 
be safely expected to compromise the overall cellular redox 
homeostasis in these organisms. 
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Bonilla et al. Supplemental Fig. 1.  
 
Mass spec of tryptic digest of TGR incubated with GSSG under different 
conditions and applied to a PD10 column to remove GSSG.  
 
Sample 1: 10 nM TGR, 1 mM GSSG, 1 minute incubation with NADPH (enzyme 
under hysteresis) 
 
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Sample 2: 10 nM TGR, 1 mM GSSG, 10 minutes incubation with NADPH 
(hysteresis relieved) 
 
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Sample 3: 10 nM TGR, 0.03 mM GSSG, 1 minute incubation without NADPH 
(conditions of no hysteresis) 
 
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Sample 4: 10 nM TGR, 0.03 mM GSSG, 1 minute incubation with NADPH 
(conditions of no hysteresis) 
 
C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251) 
 
A. Native peptide range 
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B. Glutathionylated peptide range 
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93) 
 
A. Native peptide range 
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B. Glutathionylated  peptide range 
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Bonilla et al. Supplemental Figure 2 
 
E. granulosus TGR       ------------------------------------------------------------ 
F. hepatica TGR         ------------------------------------------------------------ 
S. japonicum TGR        ------------------------------------------------------------ 
S. mansoni TGR          ------------------------------------------------------------ 
D. rerio TGR            ------------------------------------------------------------ 
X. laevis TGR           ------------------------------------------------------------ 
H. sapiens TGR          GVRVASEGSVRRPSGPVPAPQPPAFRFVSRPGRARSESETLERSPPQSPGPGKAGDAPNR  60 
H. sapiens TR           ------------------------------------------------------------ 
H. sapiens GR           ------------------------------------------------------------ 
H. sapiens Grx          ------------------------------------------------------------ 
                                                                     
E. granulosus TGR       ----------------------MAPI---GGSAEQVEKLRNKINNAAVLVFAKSFCPYCK  35 
F. hepatica TGR         ----------------------MAPI-----PDDTSSWVKKTINSSAVLLFSKSRCPYCR  33 
S. japonicum TGR        ---MFWFRSFCMIGGFCSNSFNMPP------IDGTSQWLQRTIESAAVIVFSKTTCPFCK  51 
S. mansoni TGR          ----------------------MPP------ADGTSQWLRKTVDSAAVILFSKTTCPYCK  32 
D. rerio TGR            ----------------------MPPIENDAGREQIRSKIKELIDSSAVVVFSKSFCPFCV  38 
X. laevis TGR           ----------------------MPPT----GRDLLQARVKELIDSNRVMVFSKSFCPYCD  34 
H. sapiens TGR          RSGHVRGARVLSPPGRRARLSSPGPSRSSEAREELRRHLVGLIERSRVVIFSKSYCPHST 120 
H. sapiens TR           ------------------------------------------------------------ 
H. sapiens Grx          ---------------------------------MAQEFVNCKIQPGKVVVFIKPTCPYCR  27 
                                                                      
E. granulosus TGR       KVMERFNNLKIPFGYLDLDLKKNG---SDYQKMLQEITGRTTVPQVFFRGEFIGGCDDVM  92 
F. hepatica TGR         AVKQIFNDDKVNHAVIELDKRPDG---AKIQQVLSQISGISTVPQVFVRGEFVGDSSTIS  90 
S. japonicum TGR        KLKDVLAEAKIKHATIELDQLSNG---SVIQKALSNFSKIETVPQMFVRGKFIGDSKAVL 108 
S. mansoni TGR          KVKDVLAEAKIKHATIELDQLSNG---SAIQKCLASFSKIETVPQMFVRGKFIGDSQTVL  89 
D. rerio TGR            KVKDLFKELNVKCNTIELDLMEDG---TNYQDLLHEMTGQKTVPNVFINKKHIGGCDNTM  95 
X. laevis TGR           RVKDLFSSLGAEYHSLELDECDDG---SDIQEALQELTGQKTVPNVFVNKTHVGGCDKTL  91 
H. sapiens TGR          RVKELFSSLGVECNVLELDQVDDG---ARVQEVLSEITNQKTVPNIFVNKVHVGGCDQTF 177 
H. sapiens TR           ------------------------------------------------------------  
H. sapiens Grx          RAQEILSQLPIKQGLLEFVDITATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLV  87 
                     
E. granulosus TGR       AID-DD-TIVKKANEM--KYDYDMVIIGGGSGGLALAKESAKSGAKVALLDFVVPTPMGT 148 
F. hepatica TGR         KLKKED-KLTEVIKKN--TYDYDLVVIGGGSGGLAASKEAARFGAKTAVFDFVVPTPQDT 147 
S. japonicum TGR        NYHNNN-QLQAIVNEN--KYDYDLIIIGGGSGGLAAGKEAAKYGAKTAVLDYVEPTPMGT 165 
S. mansoni TGR          KYYSND-ELAGIVNES--KYDYDLIVIGGGSGGLAAGKEAAKYGAKTAVLDYVEPTPIGT 146 
D. rerio TGR            KAHKDG-VLQKLLGEGSEVYDYDLIVIGGGSGGLACSKEAATLGKKVMVLDYVVPTPQGT 154 
X. laevis TGR           QAHKDG-SLAKLLDDNSVTYDYDLIVIGGGSGGLACSKEAASFGKKVMVLDFVVPTPQGT 150 
H. sapiens TGR          QAYQSG-LLQKLLQED-LAYDYDLIIIGGGSGGLSCAKEAAILGKKVMVLDFVVPSPQGT 235 
H. sapiens TR           ---------MNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGT  51 
H. sapiens Grx          SLQQSGELLTRLKQIGALQ----------------------------------------- 105 
 
E. granulosus TGR       TWGLGGTCVNVGCIPKKLMHQAALLNHYMEDAKSFGWDVDKG--PHDWVKMVEGIQDHIH 206 
F. hepatica TGR         TRGLGGTCVNVGCIPKKLMHQAALLREGMPDSVHFGWKWDPEKIEHDWAQIVENIGNHIH 207 
S. japonicum TGR        TWGLGGTCVNVGCIPKKLMHQAGLLSHSLEDAQHFGWSLDKSKISHDWSTMVEGVQSHIG 225 
S. mansoni TGR          TWGLGGTCVNVGCIPKKLMHQAGLLSHALEDAEHFGWSLDRSKISHNWSTMVEGVQSHIG 206 
D. rerio TGR            AWGLGGTCVNVGCIPKKLMHQTALLGTAMEDARKFGWEFAEQ-VTHNWETMKTAVNNYIG 213 
X. laevis TGR           SWGLGGTCVNVGCIPKKLMHQAAILGQSLKDSRKFGWEYEEQ-VKHNWETMREAIQNYIG 209 
H. sapiens TGR          SWGLGGTCVNVGCIPKKLMHQAALLGQALCDSRKFGWEYNQQ-VRHNWETMTKAIQNHIS 294 
H. sapiens TR           RWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEET-VKHDWDRMIEAVQNHIG 110 
H. sapiens Grx          ------------------------------------------------------------ 
                                                                   
E. granulosus TGR       ALNFGYRSSMMNANVKYLNALGEIVDPHTIKTTNKQGIVKNITTNTIIVATGERPRYPPI 266 
F. hepatica TGR         SLNWGYRTQLRSINVEYVNAFAEVVDPHTIKYTKKNKETGTVTAKVIILATGERPRYPGI 267 
S. japonicum TGR        SLNWGYKVSLRDNAVTYLNARGMLLNPHEVQITEKNKKVSTITGNKIILATGERPKYPEI 285 
S. mansoni TGR          SLNWGYKVALRDNQVTYLNAKGRLISPHEVQITDKNQKVSTITGNKIILATGERPKYPEI 266 
D. rerio TGR            SLNWGYRVSLRDKNVNYVNAYAEFVEPHKIKATNKRGKETFYTAAQFVLATGERPRYLGI 273 
X. laevis TGR           SLNWGYRVALRDKQVRYENAYGEFVESHKIKATNKKGKESFFTAEKFVVATGERPRYLNI 269 
H. sapiens TGR          SLNWGYRLSLREKAVAYVNSYGEFVEHHKIKATNKKGQETYYTAAQFVIATGERPRYLGI 354 
H. sapiens TR           SLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGI 170 
H. sapiens Grx          ------------------------------------------------------------  
 
 
 
 
 
 
E. granulosus TGR       PGAKEYGITSDDLFTLDHNPGKTLCVGASYVSLECAGFLSSIGCDVTVMVRSIFLRGFDQ 326 
F. hepatica TGR         PGDKEYAITSDDLFWLPYPPGKTLVVGASYVALECAGFLTRFGFDTTVMVRSIFLRGFDQ 327 
S. japonicum TGR        PGAIEYGITSDDLFSLPYFPGKTLVVGASYVALECAGFLASLGGDVTVMVRSILLRGFDQ 345 
S. mansoni TGR          PGAVEYGITSDDLFSLPYFPGKTLVIGASYVALECAGFLASLGGDVTVMVRSILLRGFDQ 326 
D. rerio TGR            PGDKEFCITSDDLFSLPYCPGKTLVVGASYVALECGGFLAGLGLDVTIMVRSILLRGFDQ 333 
X. laevis TGR           PGDKEYCITSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDATVMVRSIFLRGFDQ 329 
H. sapiens TGR          QGDKEYCITSDDLFSLPYCPGKTLVVGASYVALECAGFLAGFGLDVTVMVRSILLRGFDQ 414 
H. sapiens TR           PGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQ 230 
H. sapiens Grx          ------------------------------------------------------------            
 
E. granulosus TGR       QMAGLISDYIAKYGVKFVRPCVPTSVRCLEEYDPESGKLAIYEVEGKHEDG-TPFKDT 383 
F. hepatica TGR         QMADMIGEYMKEHGTKFVRSCVPTAIEEIEARDKENQKPGLYRVKGKYENG-EEFVGE 384 
S. japonicum TGR        QMAEKVGDYMENHGVKFAKLCVPDEITQLKPVDTENNKPGLLLVKGHYTDG-KKFEEE 402 
S. mansoni TGR          QMAEKVGDYMENHGVKFAKLCVPDEIKQLKVVDTENNKPGLLLVKGHYTDG-KKFEEE 383 
D. rerio TGR            DMADRAGEYMETHGVKFLRKFVPTKIEQLEA-----GTPGRIKVTAKSTESEEFFEGE 386 
X. laevis TGR           EMANRAGAYMETHGVKFIKQFVPIKVELLEE-----GTPGRIKVTAKSTQGDQIIEDE 382 
H. sapiens TGR          EMAEKVGSYMEQHGVKFLRKFIPVMVQQLEK-----GSPGKLKVLAKSTEGTETIEGV 467 
H. sapiens TR           DMANKIGEHMEEHGIKFIRQFVPIKVEQIEA-----GTPGRLRVVAQSTNSEEIIEGE 283 
H. sapiens Grx          ----------------------------------------------------------              
 
E. granulosus TGR       FNTVLFAVGRDPCTTNIGLQNVDVKT--TNGRVVVDDEERTNVPNIYAIGDVSNAGYQLT 441 
F. hepatica TGR         FNTIVMAIGRDPTWDRKAMESVGLKLD-KAKRVICADNEQSSVDSIYAIGDIVSGKPQLT 443 
S. japonicum TGR        FETVIFAVGREPQLSKLNCEAVGVKLD-KNGRVVCSDDEQTTVSNIYAIGDINAGKPQLT 461 
S. mansoni TGR          FETVIFAVGREPQLSKVLCETVGVKLD-KNGRVVCTDDEQTTVSNVYAIGDINAGKPQLT 442 
D. rerio TGR            YNTVLIAVGRDACTGKIGLDKAGVKINEKNGKVPVNDEEQTNVPHIYAIGDILEGKWELT 446 
X. laevis TGR           YNTVLIAVGRDACTRNIGLEKIGVKINERNGKIPVSDEEQTSVPHVYAIGDILDGKLELT 442 
H. sapiens TGR          YNTVLLAIGRDSCTRKIGLEKIGVKINEKSGKIPVNDVEQTNVPYVYAVGDILEDKPELT 527 
H. sapiens TR           YNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELT 343 
H. sapiens Grx          ------------------------------------------------------------ 
 
E. granulosus TGR       PLAIQAGKNLARRLYTADDCRTDYTNVPTTVFTPLEYGCIGLSEENAISKFGEDNIEVF 500 
F. hepatica TGR         PVAIHAGRYLARRLYAGDIELTDYVNVPTTIFTPIEYGACGLSEEDAITKYGKENIEVY 502 
S. japonicum TGR        PVAIHAGRYLARRLFAGATELTDYSNVATTVFTPLEYGACGLSEEDAIEKYGDNDIEVY 520 
S. mansoni TGR          PVAIQAGRYLARRLFAGATELTDYSNVATTVFTPLEYGACGLSEEDAIEKYGDKDIEVY 501 
D. rerio TGR            PVAIQAGKLLARRLYAGATMKCDYVNVPTTVFTPMEYGSCGHPEEKAIQMYGQENLEVY 505 
X. laevis TGR           PVAIQAGRLLARRLYRGSKVKCDYINVPTTVFTPLEYGCCGYAEEKAIEIYGEENLEVY 501 
H. sapiens TGR          PVAIQSGKLLAQRLFGASLEKCDYINVPTTVFTPLEYGCCGLSEEKAIEVYKKENLEIY 586 
H. sapiens TR           PVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVY 402 
H. sapiens Grx          -----------------------------------------------------------             
 
E. granulosus TGR      HSYFQPLEWTVPHRPDNTCYAKLIINKQDDNRVVGFHVFGPNAGEVTQGYAVAMHLGAR 559 
F. hepatica TGR        HSHFIPLEWTVPHRPED-GYAKIICLKSDSERVIGLHVLGPNAGEMTQGFSVAMKAGAT 560 
S. japonicum TGR       HSHFKPLEWTVAHREDNVCYMKLVCRISDNMRVLGLHVLGPNAGEITQGYAVAIKMGAT 579 
S. mansoni TGR         HSNFKPLEWTVAHREDNVCYMKLVCRKSDNMRVLGLHVLGPNAGEITQGYAVAIKMGAT 560 
D. rerio TGR           HSLFWPLEFTVPGRDNNKCYAKIICNKLDNLRVIGFHYLGPNAGEVTQGFGAAMKCGIT 564 
X. laevis TGR          HTLFWPLEWTVPSRDNNTCFAKIICNKQDNDRVIGFHVLGPNAGEITQGFGAAMKCGLT 560 
H. sapiens TGR         HTLFWPLEWTVAGRENNTCYAKIICNKFDHDRVIGFHILGPNAGEVTQGFAAAMKCGLT 645 
H. sapiens TR          HSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLT 461 
H. sapiens Grx         ----------------------------------------------------------- 
                                                      
E. granulosus TGR       KEDFDRTIGIHPTCSETFTTLRVTKSSGASATVTGCUG 597 
F. hepatica TGR         KADFDRTIGIHPTCFEGFTTMHVTKDSGASAKVTACUG 598 
S. japonicum TGR        KEDFDRTIGIHPTCSETFTTLHVTKRSGGSAAVTGCUG 615 
S. mansoni TGR          KADFDRTIGIHPTCSETFTTLHVTKKSGVSPIVSGCUG 598 
D. rerio TGR            KDQLDNTIGIHPTCAEIFTTMEVTKSSGGDITQSGCUG 602 
X. laevis TGR           KEKLDETIGIHPTCAEIFTTMDTSKSSGGDISQKGCUG 596 
H. sapiens TGR          KQLLDDTIGIHPTCGEVFTTLEITKSSGLDITQKGCUG 683 
H. sapiens TR           KKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG 499 
H. sapiens Grx          --------------------------------------  
 
 
Alignment of thioredoxin glutathione reductases (TGR), thioredoxin reductase (TR) and 
glutaredoxin (Grx). Cysteine and selenocysteine (U) residues involved in catalysis are 
highlighted in yellow. Cysteine residues glutathionylated by oxidized glutathione are shown 
in light blue. Accession numbers (ExPASy Proteomics Server): Echinococcus granulosus TGR 
(Q869D6), Fasciola hepatica TGR (A8E0R8), Schistosoma mansoni TGR (Q962Y6), Schistosoma 
japonicum TGR (Q5DE05), Danio rerio TGR (A8WGN7), Xenopus laevis TGR (Q66J56), human TGR 
(Q86VQ6), human cytosolic TR (Q16881) and human Grx (P35754). 
Bonilla et al. Supplemental Table 1. Primers used for cloning 
 
The sequences underlined correspond to the Sec insertion sequence (SECIS) of the 
E.coli formate dehydrogenase H (FDH H).  
* The 6XHis-TRGCUG construct was generated using the 6XHis-TGRGCUG construct as a 
template, and so the reverse primer for this construct anneals to the end of the E.coli 
FDH H SECIS present in this template. 
Note: To generate the 6XHis-cTrx construct the cTrx coding sequence was subcloned 
from a pGEM clone provided by Cora Chalar (Universidad de la República, Uruguay).  
 
forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse
6XHis-TRGCUG
5'-CCGGATCCCATATGAAATACGATTATGACATG-3'
5'-CGTCGACGAGCTAGGGATTGGTGCAGA-3' *
6XHis-mtTrx
5'-CGGATCCAATATTCAAGATCCTGCC-3'
5'-CAAGCTTACTACTTGCACAGCTCCTG-3'
6XHis-TGRGC*
5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'
5'-GTCGACTTAACCTTAGCAGCCGGTTA-3'
6XHis-TGRGUCG
5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'
5'_GTCGACCGATCGGGTTATTGGTGCAGACCTGCAACCGA
TTAACCACATCAGCCGGTTACGGT-3'
6XHis-TGRGCUG
5'-ATGGCTCCAATAGGTGGTTCTGC-3'
5'_GGAAGCTTGTGGATCCGAGCTAGGGATTGGTGCAGAC
CTGCAACCGATGCTTAACCTCAGCAGCCGGTTACGGT-3'
6XHis-TGRGCCG
5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'
5'-CGTCGACTTAACCGCAGCAGCCGGTTA-3'
mtTrx-EGFP
5'-CAAGCTTGTCGCCACCATGATGCTGGGTCAGAAACTC-3'
5'-AGGATCCACTTGCACAGCTCCTGAA-3'
mtTGR-EGFP
5'-CAAGCTTCGCCACCATGTTTGGCTGTCATTGTCT-3'
5'-TGGATCCCATCATCGTCAATCGCCATCA-3'
